This inventor holds 1 USPTO granted patent. Top assignee: British Biotech Pharmaceuticals Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Innovations of Peter Duncan Brown
Introduction
Peter Duncan Brown is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work focuses on the use of matrix metalloprotease (MMP) inhibitors, which have shown promise in promoting tumor regression and inhibiting cancer cell proliferation.
Latest Patents
Peter Duncan Brown holds 1 patent related to the use of MMP inhibitors. This patent details various known compounds that can be utilized in the preparation of agents aimed at combating cancer. His innovative approach has the potential to advance therapeutic options for patients suffering from this disease.
Career Highlights
Peter is currently associated with British Biotech Pharmaceuticals Limited, where he continues to develop and refine his research. His expertise in the pharmaceutical industry has positioned him as a key player in the fight against cancer.
Collaborations
Throughout his career, Peter has collaborated with talented individuals such as Lindsay Jayne Bawden and Karen Margrete Miller. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field.
Conclusion
Peter Duncan Brown's contributions to the field of pharmaceuticals, particularly through his patent on MMP inhibitors, highlight his commitment to advancing cancer treatment. His work continues to inspire and pave the way for future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile